Facultad Nacional de Salud Publica Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2009
NCT00805558
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Facultad Nacional de Salud Publica

Active Ingredients

Drugs in Phase 4 Trials (3)

ciprofloxacin (cipro) (1 trial)

metronidazole (flagyl) (1 trial)

moxifloxacin (avelox) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aggression (Phase 4)

Aggressive Periodontitis (Phase 4)

Chronic Periodontitis (Phase 4)

Periodontitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3